Related Experiment Video

Updated: Apr 10, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

The Role of miR-21 in Cancer

Susan R Pfeffer1, Chuan He Yang1, Lawrence M Pfeffer1

  • 1Department of Pathology and Laboratory Medicine and Center for Cancer Research, University of Tennessee Health Science Center, Memphis, TN, USA.

Drug Development Research
|June 18, 2015
PubMed

Insights

MicroRNAs (miRNAs) are small molecules that regulate gene expression and play a role in cancer development. This study focuses on miR-21, an oncogenic miRNA, and its impact on cancer progression and therapy resistance.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression.
  • miRNAs are implicated in various human cancers, acting as oncogenes or tumor suppressors.
  • Altered miRNA expression is linked to cancer progression, metastasis, and therapy resistance.

Purpose of the Study:

  • To explore the role of miR-21 in different cancer types.
  • To elucidate how miR-21 regulates cancer cell proliferation, migration, and apoptosis.
  • To understand miR-21's mechanism in suppressing tumor suppressor genes.

Main Methods:

  • Review of existing literature on miRNA expression in cancer.
  • Analysis of miR-21's target genes and regulatory pathways.
  • Correlation of miR-21 expression patterns with clinical outcomes.

Main Results:

  • miR-21 is identified as an oncogenic miRNA with a significant role in various cancers.
  • miR-21 promotes cancer cell proliferation and migration.
  • miR-21 contributes to apoptosis resistance by downregulating tumor suppressors.

Conclusions:

  • miR-21 is a critical oncogenic miRNA in cancer development and progression.
  • Targeting miR-21 may offer a therapeutic strategy for cancer treatment.
  • Altered miRNA expression patterns, particularly miR-21, hold potential as cancer biomarkers.
Keywords:
FBX011IGFBP3cancermiR-21miRNA

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

854

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.3K